Relasin-HC Interactions
There are 780 drugs known to interact with Relasin-HC (chlorpheniramine / hydrocodone / phenylephrine), along with 24 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 237 are major, 539 are moderate, and 4 are minor.
- View all 780 medications that may interact with Relasin-HC
- View Relasin-HC alcohol/food interactions (2)
- View Relasin-HC disease interactions (24)
Most frequently checked interactions
View interaction reports for Relasin-HC (chlorpheniramine / hydrocodone / phenylephrine) and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- Ambien (zolpidem)
- amitriptyline
- Aspir 81 (aspirin)
- aspirin
- Ativan (lorazepam)
- atorvastatin
- Capoten (captopril)
- cefuroxime
- clonazepam
- Colace (docusate)
- Coumadin (warfarin)
- cyclobenzaprine
- Depakote (divalproex sodium)
- Eliquis (apixaban)
- famotidine
- finasteride
- Flexeril (cyclobenzaprine)
- Flomax (tamsulosin)
- gabapentin
- hydrocodone
- isosorbide mononitrate
- lansoprazole
- Lantus (insulin glargine)
- Lasix (furosemide)
- Lassars Zinc (zinc oxide topical)
- meclizine
- metformin
- Metoprolol Tartrate (metoprolol)
- ropinirole
Relasin-HC alcohol/food interactions
There are 2 alcohol/food interactions with Relasin-HC (chlorpheniramine / hydrocodone / phenylephrine).
Relasin-HC disease interactions
There are 24 disease interactions with Relasin-HC (chlorpheniramine / hydrocodone / phenylephrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- BPH
- diabetes
- glaucoma
More about Relasin-HC (chlorpheniramine / hydrocodone / phenylephrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.